The Options 2 Study
Key facts
- Who runs it
- University of Wisconsin, Madison
- Where
- Madison, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 300 people, planned
- Started
- 21 May 2025
- Expected to end
- 30 Jul 2029
- Type of study
- Interventional, 4 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Nicotine Pouches
- Mini Nicotine lozenges
- Record updated
- 22 June 2026
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- ≥ 21 years old (i.e., able to legally purchase tobacco products)
- able to read and communicate in English
- no plans to quit smoking in the next 30 days
- willing to stop using nicotine replacement or varenicline
- willing to stop using bupropion (i.e., Wellbutrin, Zyban) if they are currently using it only for smoking cessation
- smoking ≥ 5 cigarettes per day for the past 6 months
- exhaled carbon monoxide ≥ 6 ppm
- no nicotine pouch or smokeless tobacco (including snus) use within the last 6 months
Who cannot take part
- currently taking bupropion for non-smoking cessation reasons (e.g., Wellbutrin for depression)
- currently in treatment for psychosis or bipolar disorder
- currently pregnant or breastfeeding
This trial is currently available in United States.
- University of WisconsinMadison, United StatesContact: Megan Piper, PhDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to investigate how well nicotine pouches and nicotine mini lozenges serve as substitutes for cigarettes when people try to switch from smoking to using these alternate nicotine products.
Read full original descriptionShow less
Participants will:
* Use nicotine pouches, nicotine mini lozenges, or no study product for a week and then try not to smoke for 3 weeks. * Have 6 in-person research visits and 1 follow-up call * Complete questionnaires at each study contact and use a smartphone app to record smoking and study product use
The 4 groups in the trial
- 3mg Nicotine PouchesTreatment being tested
Participants will use 3mg nicotine pouches
Treatment: Nicotine Pouches
- 6mg Nicotine PouchesTreatment being tested
Participants will use 6mg nicotine pouches
Treatment: Nicotine Pouches
- Nicotine Mini LozengesTreatment being tested
Participants will use mini lozenges with dosing based on time to first cigarette (2mg or 4mg)
Treatment: Mini Nicotine lozenges
- No Study ProductNo study treatment, for comparison
Participants randomized to this arm will use a mint candy during two different 30-minute laboratory sessions only.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Comparative Effectiveness Trial of Nicotine Pouches for Cigarette Substitution: A Question of Public Health
- Record updated
- 22 June 2026